STAT+: Novartis CEO joins Anthropic’s board

Revolution Medicines $2B fundraise, Structure's new hire hints at acquisition efforts, and more Readout biotech news
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

Revolution Medicines $2B fundraise, Structure's new hire hints at acquisition efforts, and more Readout biotech news
Source
Stat News
Opens original article in a new tab

(MedPage Today) -- In branding, marketing, and advertising, imagery is everything. It's not just what you say that matters. It's just as important what shows up on the screen and what the people who see it are meant to feel. The Make America Healthy...

(MedPage Today) -- The FDA will hold a meeting this summer to consider easing restrictions on more than a half-dozen peptide injections, a group of unapproved therapies that have become popular among wellness influencers, fitness gurus, and celebrities...

(MedPage Today) -- A small number of "superretractors" was responsible for a significant proportion of retracted clinical trials, a retrospective cohort study showed. Just six superretractors accounted for about a fifth of all retracted randomized...

(MedPage Today) -- A former longtime University of California Los Angeles (UCLA) gynecologist at the center of a sexual misconduct scandal that prompted the school to pay $700 million to settle hundreds of claims pleaded guilty Tuesday to sexual...